🔍

VITAL - Vital Chemtech

📊 NSE: VITAL 🏢 Chemicals 📅 Last Updated: 12/14/2025 15:11

📢 Recent Corporate Announcements

Vital Chemtech Shareholders Approve Secretarial Auditor Appointment for 5-Year Term

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 27 Apr 2026, 04:39 PM

Vital Chemtech Limited has successfully passed an ordinary resolution via postal ballot to appoint M/s. SCS and Co. LLP as the company's Secretarial Auditor. The appointment is set for a five-year term covering Financial Years 2025-26 through 2029-30. The resolution received unanimous support, with 100% of the 1,79,94,901 votes cast in favor. This administrative step ensures the company remains compliant with SEBI and Companies Act regulations regarding secretarial audits.

Appointment of M/s. SCS and Co. LLP as Secretarial Auditor for a 5-year term starting FY 2025-26.
Resolution passed with 100% of votes in favor, totaling 1,79,94,901 votes.
Total voter turnout represented 75.13% of the company's outstanding shares.
Promoter and Promoter Group accounted for 1,75,87,500 votes, all in favor.

💡 No action is required as this is a routine regulatory appointment. Investors should view this as a standard corporate governance procedure to maintain compliance.

Vital Chemtech Shareholders Approve Secretarial Auditor Appointment for 5-Year Term

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 27 Apr 2026, 03:48 PM

Vital Chemtech Limited has successfully passed an ordinary resolution via postal ballot to appoint M/s. SCS and Co. LLP as the company's Secretarial Auditor. The appointment is set for a five-year term spanning from the financial year 2025-26 to 2029-30. The resolution received unanimous support, with 100% of the 17,994,901 votes polled being in favor. This administrative move ensures the company remains compliant with statutory governance requirements for the upcoming years.

Appointment of M/s. SCS and Co. LLP as Secretarial Auditor for a five-year term (FY 2025-26 to 2029-30).
Resolution passed with 100% of votes in favor, totaling 17,994,901 votes.
Total voter turnout represented 75.13% of the company's 23,951,100 outstanding shares.
Promoter group cast 17,587,500 votes (100% of their holding) in favor of the resolution.
Public non-institutional shareholders contributed 407,401 votes, all in favor.

💡 This is a routine corporate governance matter with no direct impact on stock valuation; investors should view it as a standard regulatory compliance step.

Vital Chemtech Seeks Shareholder Approval for Secretarial Auditor Appointment for 5-Year Term

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 25 Mar 2026, 06:17 PM

Vital Chemtech Limited has issued a Postal Ballot notice to seek shareholder approval for the appointment of M/s. SCS and Co. LLP as the company's Secretarial Auditor. The proposed appointment is for a five-year term spanning from Financial Year 2025-26 to 2029-30. The voting process is conducted entirely through electronic means, with the voting window open from March 26 to April 24, 2026. This is a standard regulatory requirement under the Companies Act, 2013, to ensure corporate governance and compliance.

Proposed appointment of M/s. SCS and Co. LLP as Secretarial Auditor for a 5-year consecutive term.
The audit term covers Financial Years 2025-26 through 2029-30.
E-voting period is scheduled from March 26, 2026, to April 24, 2026.
The cut-off date for determining shareholder eligibility to vote was March 20, 2026.
The resolution is proposed as an Ordinary Resolution based on Audit Committee recommendations.

💡 This is a routine governance matter; shareholders should review the notice and cast their votes by the April 24 deadline. No specific impact on stock price is expected from this administrative update.

Vital Chemtech Grants 2,32,300 ESOPs Under 2025 Scheme at Rs 10 Per Share

🟡 NEUTRAL ⭐ 4/10

MANAGEMENT 📅 24 Mar 2026, 04:09 PM

Vital Chemtech Limited has granted 2,32,300 equity stock options to eligible employees under its Vital Employee Stock Option Scheme-2025. These options are priced at the face value of Rs 10 per share, which acts as an incentive for employee retention and performance. The vesting period for these options is set between one and three years from the date of grant. Once vested, employees will have a 60-day window to exercise their options into equity shares of the company.

Grant of 2,32,300 equity stock options to eligible employees of the company and its group companies
Options granted at a face value price of Rs 10 per share
Vesting period defined as minimum 1 year and maximum 3 years from the grant date
Exercise period is 60 days from the date of closure of the vesting period
The scheme is compliant with SEBI (Share Based Employee Benefits) Regulations, 2021

💡 No immediate action is required as this is a routine management measure for employee retention. Investors should be aware of the marginal equity dilution that will occur when these options are exercised in the future.

Vital Chemtech Appoints Internal and Secretarial Auditors for FY 2025-26

🟡 NEUTRAL ⭐ 4/10

MANAGEMENT 📅 24 Mar 2026, 03:54 PM

Vital Chemtech Limited has announced the appointment of M/s Ravi V. Patel & Co. as the Internal Auditor for the financial year 2025-26. Furthermore, the Board has approved the appointment of M/s. SCS and Co. LLP as Secretarial Auditors for a five-year term from FY 2025-26 to FY 2029-30. The company will conduct a Postal Ballot to seek shareholder approval for the Secretarial Auditor's appointment. These appointments are part of the company's routine governance and compliance measures for the upcoming fiscal periods.

M/s Ravi V. Patel & Co. appointed as Internal Auditor for the Financial Year 2025-26.
M/s. SCS and Co. LLP appointed as Secretarial Auditor for a 5-year consecutive term (FY 2025-26 to FY 2029-30).
Postal Ballot process initiated to obtain shareholder approval for the Secretarial Auditor appointment.
M/s. Mittal V. Kothari & Associates appointed as Scrutinizer for the Postal Ballot e-voting process.
NSDL selected as the e-voting agency for the upcoming shareholder resolution.

💡 These are routine administrative and compliance-related appointments. No immediate action is required from investors, though they should participate in the upcoming postal ballot voting.

Vital Chemtech Appoints Internal and Secretarial Auditors for FY 2025-26

🟡 NEUTRAL ⭐ 3/10

MANAGEMENT 📅 24 Mar 2026, 03:50 PM

Vital Chemtech Limited has announced the appointment of M/s Ravi V. Patel & Co. as Internal Auditor for the financial year 2025-26. Additionally, the Board has approved the appointment of M/s SCS and Co. LLP as Secretarial Auditors for a five-year term from FY 2025-26 to FY 2029-30. The company is initiating a Postal Ballot process to obtain shareholder approval for the Secretarial Auditor's long-term appointment. These appointments are part of the company's routine governance and regulatory compliance framework.

M/s Ravi V. Patel & Co. appointed as Internal Auditor for the Financial Year 2025-26.
M/s SCS and Co. LLP appointed as Secretarial Auditor for a 5-year tenure (FY 2025-26 to FY 2029-30).
Postal Ballot process initiated to seek member approval for the Secretarial Auditor appointment.
M/s Mittal V. Kothari & Associates appointed as Scrutinizer for the Postal Ballot e-voting process.

💡 These are routine governance appointments required by law and do not impact the company's financial fundamentals. No specific action is required other than participating in the upcoming Postal Ballot if a shareholder.

Vital Chemtech Appoints New Auditors and Approves Postal Ballot Process

🟡 NEUTRAL ⭐ 3/10

BOARD_MEETING 📅 24 Mar 2026, 03:45 PM

Vital Chemtech Limited held a board meeting on March 24, 2026, to finalize key governance and compliance appointments. The board appointed M/s Ravi V. Patel & Co. as the Internal Auditor for the financial year 2025-26. Furthermore, M/s SCS and Co. LLP has been appointed as the Secretarial Auditor for a five-year term from FY 2025-26 to FY 2029-30, subject to shareholder approval. The company is initiating a Postal Ballot to seek member consent for these administrative decisions.

Appointment of M/s Ravi V. Patel & Co. as Internal Auditor for the financial year 2025-26.
M/s SCS and Co. LLP appointed as Secretarial Auditor for a 5-year tenure (FY 2025-26 to FY 2029-30).
Approval of the draft Postal Ballot Notice to seek necessary shareholder approvals.
NSDL appointed as the e-voting agency and M/s Mittal V. Kothari & Associates as the Scrutinizer for the ballot process.

💡 These are routine administrative and governance updates required by SEBI regulations. No immediate action is required from investors other than reviewing the upcoming Postal Ballot notice for voting.

Vital Chemtech Migrates to NSE Main Board Effective March 11, 2026

🟢 POSITIVE ⭐ 7/10

REGULATORY 📅 10 Mar 2026, 11:33 AM

Vital Chemtech Limited has received final approval from the National Stock Exchange (NSE) to migrate its equity shares from the SME Emerge platform to the Main Board. Trading on the Main Board will commence on March 11, 2026, involving 2,39,51,100 equity shares with a face value of Rs. 10 each. This transition is a significant milestone that typically enhances stock liquidity and visibility. The migration follows the company's initial listing on the SME platform in November 2022.

Migration from NSE SME Emerge platform to the NSE Main Board effective March 11, 2026
Total of 2,39,51,100 equity shares of face value Rs. 10 each to be admitted for trading
Market lot size reduced to 1 share from previous SME lot requirements, improving retail accessibility
Final approval received via NSE circular Ref. No. NSE/CML/73204 dated March 09, 2026

💡 Investors should monitor the stock for increased liquidity and potential institutional interest following the migration. The removal of SME lot size restrictions makes the stock more accessible for retail portfolios.

View All VITAL Announcements on Live Market Tracking →

💰 Financial Performance

Revenue Growth by Segment

Not disclosed in available documents. The provided financial statements focus on the Balance Sheet as of September 30, 2025, rather than segmented revenue growth.

Profitability Margins

Not disclosed in available documents. Profit and loss figures for the half-year ended September 30, 2025, were not included in the provided text fragments.

Capital Expenditure

As of September 30, 2025, the company reported total assets of INR 129.14 Cr (12,913.51 Lakhs), a 1.5% increase from INR 127.23 Cr (12,722.92 Lakhs) on March 31, 2025. Specific planned CapEx figures are not disclosed.

Credit Rating & Borrowing

The company has reduced its long-term borrowings by 40.8%, from INR 1.20 Cr (120.05 Lakhs) in March 2025 to INR 0.71 Cr (71.11 Lakhs) in September 2025. Short-term borrowings also decreased by 5.2% to INR 11.21 Cr (1,121.38 Lakhs). Specific credit ratings and interest rates are not disclosed.

⚙️ Operational Drivers

Raw Materials

Not disclosed in available documents. However, the company operates in the chemical sector with a subsidiary named Vital Alkoxides Private Limited, implying the use of alcohols and alkali metals as primary inputs.

📈 Strategic Growth

Growth Strategy

The company is pursuing a major strategic transition by migrating its securities from the NSE Emerge (SME) platform to the Main Boards of both the National Stock Exchange (NSE) and BSE Limited. This move is intended to enhance liquidity, attract institutional investors, and improve the company's valuation profile. Growth is also supported by its subsidiaries, Vital Synthesis Limited and Vital Alkoxides Private Limited, which focus on specialized chemical manufacturing.

Products & Services

Chemical products, specifically alkoxides (via Vital Alkoxides Private Limited) and other synthesized chemical compounds.

Brand Portfolio

Vital Chemtech

Market Expansion

The company is expanding its capital market presence by moving from the SME platform to the Main Boards of NSE and BSE as of November 2025.

Strategic Alliances

The company operates through subsidiaries: Vital Synthesis Limited and Vital Alkoxides Private Limited.

🌍 External Factors

Industry Trends

The Indian specialty chemical industry is currently seeing a shift toward domestic manufacturing and import substitution. Vital Chemtech's positioning in alkoxides and synthesis aligns with this trend, as these are critical intermediates for various industrial applications.

Competitive Landscape

The company operates in the competitive chemical manufacturing sector, transitioning from an SME-scale player to a Main Board-listed entity.

Competitive Moat

The company's moat is currently limited by its SME status, but the migration to the Main Board and its specialized focus on alkoxides provide a platform for scaling. Its low debt-to-equity ratio (approx 0.13 based on INR 11.92 Cr debt vs INR 93.98 Cr equity) provides a sustainable financial cushion for expansion.

⚖️ Regulatory & Governance

Industry Regulations

The company is currently exempt from certain Corporate Governance requirements (Regulation 27(2) of SEBI LODR) because it is listed on the SME Exchange and has a paid-up capital below INR 10 Cr and net worth below INR 25 Cr (as of the previous financial year criteria). However, this will change upon migration to the Main Board.

Taxation Policy Impact

The company reports Deferred Tax Liabilities of INR 0.59 Cr (58.88 Lakhs) as of September 30, 2025.

⚠️ Risk Analysis

Key Uncertainties

The primary uncertainty is the successful execution of the migration to the Main Board and the subsequent requirement to meet higher governance and disclosure standards.

Credit & Counterparty Risk

Trade payables increased significantly by 149% from INR 1.03 Cr (102.81 Lakhs) in March 2025 to INR 2.56 Cr (255.99 Lakhs) in September 2025, indicating a change in working capital management or supplier terms.